Skip to main content

Advertisement

Log in

Pancreas-sparing total duodenectomy for Spigelman stage IV duodenal polyposis associated with familial adenomatous polyposis: experience of 10 cases at a single institution

  • Original Article
  • Published:
Familial Cancer Aims and scope Submit manuscript

Abstract

Duodenal cancer is a leading cause of death in patients with familial adenomatous polyposis (FAP). In patients with Spigelman’s classification (SC) stage IV duodenal polyposis (DP), careful endoscopic surveillance by specialists or surgical intervention is mandatory. We herein report the surgical and pathological outcomes of FAP patients with SC stage duodenal polyposis undergoing pancreas-sparing total duodenectomy (PSTD), which has been rarely reported but seems optimal in such patients. PSTD and distal gastrectomy with Billroth-I type reconstruction in ten consecutive FAP patients with SC stage IV DP are reported. The median duration of surgery was 396 min (range 314–571 min) and the median estimated blood loss was 480 mL (range 100–975 mL). Significant postoperative complications included wound infection in 1 patient, pancreatic fistula [International Study Group on Pancreatic Fistula definition (ISGPF) grade B] in 4 patients. Histopathologic examinations revealed a well-differentiated carcinoma in situ in 3 patients and others were all adenomas. Over a median follow-up period of 15 months (range 9–29 months), 1 patient developed a stomal ulcer which improved with medical treatment. There were no patients with a body weight loss of ≥10 % relative to the preoperative body weight. No recurrence were experienced during the follow up period. Patients were free from postoperative diabetes mellitus. PSTD is a feasible and acceptable procedure in FAP patients with SC stage IV DP, in terms of surgical, pathological and clinical outcome. However, accumulation of the patients and long-term follow up study is necessary.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Arvanitis ML, Jagelman DG, Fazio VW et al (1990) Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 33:639–642

    Article  CAS  PubMed  Google Scholar 

  2. Belchetz LA, Berk T, Bapat BV et al (1996) Changing causes of mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 39:384–387

    Article  CAS  PubMed  Google Scholar 

  3. Spigelman AD, Talbot IC, Penna C, Nugent KP, Phillips RK, Costello C et al (1994) Evidence for adenoma–carcinoma sequence in the duodenum of patients with familial adenomatous polyposis. The Leeds Castle Polyposis Group (Upper Gastrointestinal Committee). J Clin Pathol 47:709–710

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Björk J, Akerbrant H, Iselius L et al (2001) Periampullary adenomas and adenocarcinomas in familial adenomatous polyposis: cumulative risks and APC gene mutations. Gastroenterology 121:1127–1135

    Article  PubMed  Google Scholar 

  5. Bülow S, Björk J, Christensen IJ et al (2004) Duodenal adenomatosis in familial adenomatous polyposis. Gut 53:381–386

    Article  PubMed  PubMed Central  Google Scholar 

  6. de Vos tot Nederveen Cappel WH, Järvinen HJ, Björk J et al (2003) Worldwide survey among polyposis registries of surgical management of severe duodenal adenomatosis in familial adenomatous polyposis. Br J Surg 90:705–710

    Article  CAS  PubMed  Google Scholar 

  7. Spigelman AD, Williams CB, Talbot IC et al (1989) Upper gastrointestinal cancer in patients with familial adenomatous polyposis. Lancet 2:783–785

    Article  CAS  PubMed  Google Scholar 

  8. Groves CJ, Saunders BP, Spigelman AD et al (2002) Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study. Gut 50:636–641

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Skipworth JR, Morkane C, Raptis DA et al (2011) Pancreaticoduodenectomy for advanced duodenal and ampullary adenomatosis in familial adenomatous polyposis. HPB (Oxford) 13:342–349

    Article  Google Scholar 

  10. Gallagher MC, Shankar A, Groves CJ et al (2004) Pylorus-preserving pancreaticoduodenectomy for advanced duodenal disease in familial adenomatous polyposis. Br J Surg 91:1157–1164

    Article  CAS  PubMed  Google Scholar 

  11. Chung RS, Church JM, vanStolk R (1995) Pancreas-sparing duodenectomy: indications, surgical technique, and results. Surgery 117:254–259

    Article  CAS  PubMed  Google Scholar 

  12. van Heumen BW, Nieuwenhuis MH, van Goor H et al (2012) Surgical management for advanced duodenal adenomatosis and duodenal cancer in Dutch patients with familial adenomatous polyposis: a nationwide retrospective cohort study. Surgery 151:681–690

    Article  PubMed  Google Scholar 

  13. Ishikawa H, Mutoh M, Iwama T et al (2016) Endoscopic management of familial adenomatous polyposis in patioents refusing colectomy. Endoscopy 48:51–55

    Article  PubMed  Google Scholar 

  14. Bassi Claudio, Dervenis Christos, Butturini Giovanni et al (2005) Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 138:8–13

    Article  PubMed  Google Scholar 

  15. Alwmark A, Andersson A, Lasson A (1980) Primary carcinoma of the duodenum. Ann Surg 191:13–18

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Iwama T, Mishima Y, Utsunomiya J (1993) The impact of familial adenomatous polyposis on the tumorigenesis and mortality at the several organs. Its rational treatment. Ann Surg 217:101–108

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Yamaguchi T, Ishida H, Ueno H et al (2016) Upper gastrointestinal tumours in Japanese familial adenomatous polyposis patients. Jpn J Clin Oncol 46:310–315

    Article  PubMed  Google Scholar 

  18. Balmforth DC, Phillips RK, Clark SK (2012) Advanced duodenal disease in familial adenomatous polyposis: how frequently should patients be followed up after successful therapy? Fam Cancer 11:553–557

    Article  PubMed  Google Scholar 

  19. Samadder NJ, Neklason DW, Boucher KM et al (2016) Effect of Sulindac and Erlotinib on duodenal neoplasia in familial adenomatous polyposis: a randomized clinical trial. JAMA 315:1266–1275

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. von Roon AC, Will OC, Man RF et al (2011) Mucosectomy with handsewn anastomosis reduces the risk of adenoma formation in the anorectal segment after restorative proctocolectomy for familial adenomatous polyposis. Ann Surg 253:314–317

    Article  Google Scholar 

  21. van Duijvendijk P, Vasen HF, Bertario L et al (1999) Cumulative risk of developing polyps or malignancy at the ileal pouch-anal anastomosis in patients with familial adenomatous polyposis. J Gastrointest Surg 3:325–330

    Article  PubMed  Google Scholar 

  22. Penninga L, Svendsen LB (2011) Pancreas-preserving total duodenectomy: a 10-year experience. J Hepatobiliary Pancreat Sci 18:717–723

    Article  PubMed  Google Scholar 

  23. Zuidema MF, Dekker W (1989) A patient with a metastasizing jejunal carcinoma 17 years after colectomy for familial polyposis coli. Neth J Med 34:317–321

    CAS  PubMed  Google Scholar 

  24. Murakami Y, Uemura K, Sasaki M (2005) Duodenal cancer arising from the remaining duodenum after pylorus-preserving pancreatoduodenectomy for ampullary cancer in familial adenomatous polyposis. J Gastrointest Surg 9:389–392

    Article  PubMed  Google Scholar 

  25. Jagelman DG, DeCosseJJ Bussey HJ (1988) Upper gastrointestinal cancer in familial adenomatous polyposis. Lancet 21:1149–1151

    Article  Google Scholar 

  26. Ishida H, Kumamoto K, Amano K et al (2013) Identification of APC gene mutations in jejunal carcinomas from a patient with familial adenomatous polyposis. Jpn J Clin Oncol 43:929–934

    Article  PubMed  Google Scholar 

  27. Ruys AT, Alderlieste YA, Gouma DJ et al (2010) Jejunal cancer in patients with familial adenomatous polyposis. Clin Gastroenterol Hepatol 8:731–733

    Article  PubMed  Google Scholar 

  28. Iwama T, Tamura K, Morita T et al (2004) A clinical overview of familial adenomatous polyposis derived from the database of the Polyposis Registry of Japan. Int J Clin Oncol 9:308–316

    Article  PubMed  Google Scholar 

  29. Matsumoto T, Esaki M, Yanaru-Fujisawa R et al (2008) Small-intestinal involvement in familial adenomatous polyposis: evaluation by double-balloon endoscopy and intraoperative enteroscopy. Gastrointest Endosc 68:911–919

    Article  PubMed  Google Scholar 

  30. Alderlieste YA, Bastiaansen BA, Mathus-Vliegen EM et al (2013) High rate of recurrent adenomatosis during endoscopic surveillance after duodenectomy in patients with familial adenomatous polyposis. Fam Cancer 12:699–706

    Article  PubMed  Google Scholar 

  31. de Castro SM, van Eijck CH, Rutten JP et al (2008) Pancreas-preserving total duodenectomy versus standard pancreatoduodenectomy for patients with familial adenomatous polyposis and polyps in the duodenum. Br J Surg 95:1380–1386

    Article  PubMed  Google Scholar 

  32. Burke CA, Beck GJ, Church JM et al (1999) The natural history of untreated duodenal and ampullary adenomas in patients with familial adenomatous polyposis followed in an endoscopic surveillance program. Gastrointest Endosc 49:358–364

    Article  CAS  PubMed  Google Scholar 

  33. Ma T, Jang EJ, Zukerberg LR et al (2014) Recurrences are common after endoscopic ampullectomy for adenoma in the familial adenomatous polyposis (FAP) syndrome. Surg Endosc 28:2349–2356

    Article  PubMed  PubMed Central  Google Scholar 

  34. Irani S, Arai A, Ayub K et al (2009) Papillectomy for ampullary neoplasm: results of a single referral center over a 10-year period. Gastrointest Endosc 70:923–932

    Article  PubMed  Google Scholar 

  35. Catalano MF, Linder JD, Chak A et al (2004) Endoscopic management of adenoma of the major duodenal papilla. Gastrointest Endosc 59:225–232

    Article  PubMed  Google Scholar 

  36. Gluck N, Strul H, Rozner G et al (2015) Endoscopy and EUS are key for effective surveillance and management of duodenal adenomas in familial adenomatous polyposis. Gastrointest Endosc 81:960–966

    Article  PubMed  Google Scholar 

  37. Iwama T, Tomita H, Kawachi Y et al (1994) Indications for local excision of ampullary lesions associated with familial adenomatous polyposis. J Am Coll Surg 179:462–464

    CAS  PubMed  Google Scholar 

  38. Camp ER, Hochwald SN, Liu C et al (2004) FAP with concurrent duodenal adenomatous polyposis and carcinoid tumor. Surg Oncol 87:187–190

    Article  Google Scholar 

  39. July LV, Northcott KA, Yoshida EM et al (1999) Coexisting carcinoid tumors in familial adenomatous polyposis-associated upper intestinal adenomas. Am J Gastroenterol 94:1091–1094

    Article  CAS  PubMed  Google Scholar 

  40. Tsiotos GG, Sarr MG (1998) Pancreas-preserving total duodenectomy. Dig Surg 15:398–403

    Article  CAS  PubMed  Google Scholar 

  41. Sarmiento JM, Thompson GB, Nagorney DM et al (2002) Pancreas-sparing duodenectomy for duodenal polyposis. Arch Surg 137:557–563

    Article  PubMed  Google Scholar 

  42. Lundell L, Hyltander A, Liedman B (2002) Pancreas-sparing duodenectomy: technique and indications. Eur J Surg 168:74–77

    Article  CAS  PubMed  Google Scholar 

  43. Kalady MF, Clary BM, Tyler DS et al (2002) Pancreas-preserving duodenectomy in the management of duodenal familial adenomatous polyposis. J Gastrointest Surg 6:82–87

    Article  PubMed  Google Scholar 

  44. Imamura M, Komoto I, Doi R et al (2005) New pancreas-preserving total duodenectomy technique. World J Surg 29:203–207

    Article  PubMed  Google Scholar 

  45. Mackey R, Walsh RM, Chung R et al (2005) Pancreas-sparing duodenectomy is effective management for familial adenomatous polyposis. J Gastrointest Surg 9:1088–1093

    Article  PubMed  Google Scholar 

  46. Mullar MW, Dahmen R, Koninger J et al (2008) Is there an advantage in performing a pancreas-preserving total duodenectomy in duodenal adenomatosis? Am J Surg 195:741–748

    Article  Google Scholar 

  47. Al-Sarireh B, Ghaneh P, Gardner-Thorpe J et al (2008) Complications and follow-up after pancreas-preserving total duodenectomy for duodenal polyps. Br J Surg 95:1506–1511

    Article  CAS  PubMed  Google Scholar 

  48. Benetatos N, Ammori MB, Ammori BJ (2011) Laparoscopic pancreas-preserving total duodenectomy for familial adenomatous polyposis. Surg Laparosc Endosc Percutan Tech 21:e332–e335

    Article  PubMed  Google Scholar 

  49. Stauffer JA, Adkisson CD, Riegert-Johnson DL et al (2012) Pancreas-sparing total duodenectomy for ampullary duodenal neoplasms. World J Surg 36:2461–2472

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yuichiro Watanabe.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Human and animal rights

This article does not contain any studies with animals performed by any of the authors.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Watanabe, Y., Ishida, H., Baba, H. et al. Pancreas-sparing total duodenectomy for Spigelman stage IV duodenal polyposis associated with familial adenomatous polyposis: experience of 10 cases at a single institution. Familial Cancer 16, 91–98 (2017). https://doi.org/10.1007/s10689-016-9932-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10689-016-9932-2

Keywords

Navigation